Lentiviral Gene Transfer Corrects Immune Abnormalities in XIAP Deficiency

ConclusionGene correction of HSCs recovers XIAP-dependent immune defects and could offer a treatment option for patients with XIAP deficiency.
Source: Journal of Clinical Immunology - Category: Allergy & Immunology Source Type: research